Incyte Corporation (INCY) is expected to announce strong Q1 2026 results on April 28, with analysts forecasting a 36% increase in EPS to $1.21. The biopharmaceutical company has seen its stock climb 65% over the past year, outperforming the S&P 500, due to strong revenue growth from key drugs and pipeline advancements. Analysts maintain a "Moderate Buy" rating for INCY, with an average price target suggesting an 11.9% upside.

This article reviews the Q4 earnings performance of mixed or offshore upstream E&P stocks, highlighting APA Corporation (NASDAQ:APA) as an outperformer with strong revenue and EPS beats. It also covers the best performer, Gevo (NASDAQ:GEVO), and the weakest, Vitesse Energy (NYSE:VTS), along with results for Core Natural Resources (NYSE:CNR) and Seadrill (NYSE:SDRL). The piece concludes with a market update noting a shift in investor focus from AI to geopolitical risks, particularly the US's conflict with Iran impacting oil supply and inflation concerns.

PNC Financial Services Group reported first-quarter earnings that surpassed analyst expectations, driven by its acquisition of FirstBank and strong legacy loan growth. Despite missing revenue estimates, the bank achieved adjusted earnings per share of $4.32 and saw net interest income rise by 14% year-over-year. The company also returned $1.4 billion to shareholders through share repurchases and dividends.

The UK government has awarded Boeing a three-year, $1.19 billion (879 million pound) contract to maintain and support its army Apache attack helicopters and Royal Air Force Chinook heavy-lift helicopters. This agreement ensures ongoing operational readiness for these critical military aircraft.

Morgan Stanley's Bitcoin ETF has accumulated $83.6 million in holdings, signaling real institutional investment in the crypto market. Despite this significant inflow, the immediate market reaction has been muted, with Bitcoin's price expectations for April 15 remaining flat. However, long-term optimism is evident, as indicated by a 36.5% probability of Bitcoin reaching $100,000 by year-end.

BofA Securities has increased its price target for CenterPoint Energy (NYSE:CNP) stock to $44 from $42, while maintaining a Neutral rating, adjusting its valuation to 2028 using peer group multiples. The utility company's stock is currently trading near its 52-week high, and BofA analysts have updated EPS estimates, reflecting the company's target growth rate. CenterPoint Energy has also been active in financing, issuing senior secured system restoration bonds and convertible senior notes, and continues its consistent dividend payments.

Leidos Holdings is forming a joint venture with Altaris affiliates and Analogic, combining Leidos’ Security Enterprise Solutions and Industrial Automation operations with Analogic. Leidos will hold a 41.5% stake in the new company, which will operate under the Analogic brand and focus on accelerating AI-native and 3D imaging solutions for security screening. This move allows Leidos to redirect capital toward its core growth priorities under the NorthStar 2030 strategy.

Labcorp has launched a new FDA-cleared rapid fentanyl urine test that delivers results in just 10 minutes. This test detects norfentanyl, a fentanyl metabolite, offering a detection window of up to 48 hours, which assists healthcare providers in emergency departments and clinics with quick decision-making for suspected fentanyl exposure. The test is intended for preliminary screening by qualified professionals in CLIA-certified settings and results should be confirmed by laboratory methods.

Labcorp has launched the Labcorp Fentanyl Urine Visual Test, the first FDA-cleared rapid fentanyl test manufactured in the U.S. This test provides results in 10 minutes, assisting healthcare providers in emergency departments, hospitals, and clinics with quick and actionable information regarding suspected fentanyl exposure. The test detects norfentanyl, a fentanyl metabolite, offering a longer detection window and is available through Labcorp Point of Care.

Moderna (NASDAQ: MRNA) announced it will report its first-quarter 2026 financial results on Friday, May 1, 2026, with a live conference call and webcast at 8:00 a.m. ET. The company will also provide a corporate update during the call, with an archived webcast available two hours later for one year. This announcement follows a historical pattern for scheduling earnings calls, which has typically resulted in limited short-term stock price impact.